Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Am J Kidney Dis. 2021 Jul 23;79(3):393–403.e1. doi: 10.1053/j.ajkd.2021.06.018

Table 2A:

Clinical Outcomes in Hemodialysis (HD)-Dependent vs Non-HD-Dependent Patients

HD-Dependent Non-HD-Dependent P-value
n=453 n=1862
All-Cause Mortality (%) 106 (23.4) 505 (27.1) 0.1
SAB a -Attributable Mortality (%) 60 (13.2) 253 (13.6) 0.9
Persistent Bacteremia (%) 140 (30.9) 373 (20.0) <0.001
Metastatic Complications (Overall) (%) 160 (35.4) 692 (37.2) 0.5
 Metastatic Abscess (%) 31 (6.8) 164 (8.8) 0.2
 Psoas Abscess (%) 5 (1.1) 41 (2.2) 0.2
 Epidural Abscess (%) 5 (1.1) 64 (3.5) 0.01
 Endocarditis (%) 78 (17.2) 237 (12.8) 0.02
 Vertebral Osteomyelitis (%) 16 (3.5) 89 (4.8) 0.3
 Septic Arthritis (%) 25 (5.5) 137 (7.4) 0.2
 Septic Emboli (%) 32 (7.1) 105 (5.7) 0.3
 Septic Thrombophlebitis (%) 28 (6.2) 67 (3.6) 0.02

P-values marked in bold are significant.

a

Staphylococcus aureus-bacteremia